Cargando…
Comparison of multi-omics results between patients with acute myeloid leukemia with long-term survival and healthy controls
BACKGROUND: Acute myeloid leukemia (AML) is a group of highly heterogeneous diseases, for which approximately 35–40% of patients younger than 60 years old can be cured. However, the multi-omics characteristics and immune cell infiltration (ICI) status of adult long-term survival patients with AML pa...
Autores principales: | Song, Yang, Hao, Qishan, Zhang, Guangji, Fang, Qiuyun, Wang, Zhe, Li, Yan, Wei, Hui, Wang, Ying, Jiang, Erlie, Tian, Zheng, Jia, Yannan, Wang, Min, Wang, Jianxiang, Mi, Yingchang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848452/ https://www.ncbi.nlm.nih.gov/pubmed/35282130 http://dx.doi.org/10.21037/atm-21-6681 |
Ejemplares similares
-
Diagnostic challenge in mixed phenotype acute leukemia with T/megakaryocyte or T/myeloid lineages accompanied by t(3;3)
por: Jia, Yannan, et al.
Publicado: (2022) -
The impact of venetoclax based regimens in the preemptive of measurable residual disease in acute myeloid leukemia
por: Fang, Qiuyun, et al.
Publicado: (2022) -
The clinical characteristics and prognosis in adult Ph negative acute lymphoblastic leukemia with TP53 aberrations
por: Fang, Qiuyun, et al.
Publicado: (2022) -
Effects of genetic polymorphisms on methotrexate levels and toxicity in Chinese patients with acute lymphoblastic leukemia
por: Hao, Qishan, et al.
Publicado: (2022) -
Gene Deletions and Prognostic Values in B-Linage Acute Lymphoblastic Leukemia
por: Fang, Qiuyun, et al.
Publicado: (2021)